September 29, 2020

By Dr. Michael J. Cooney, Clinical Director

PHN nerve pain can be reduced with calmare scrambler therapy

Wednesday, October 7, 2020 from 1 – 4 pm

Schedule your no-fee consultation to speak with clinical director Dr. Michael Cooney to discuss your treatment-resistant postherpetic neuralgia (PHN) and how Calmare’s non-invasive therapy can significantly help relieve this type of nerve pain. Please read the background about how Calmare works to relieve nerve pain in advance. Email us at info@calmaretherapynj.com to schedule your call or call us directly at (201) 933-4440.


Shingles is also known as herpes zoster, a painful skin rash caused by the varicella-zoster virus.

Some people with Shingles, generally people over age 65, develop a notoriously painful condition called postherpetic neuralgia (PHN).

According to the Centers for Disease Control, PHN risk increases with age; additional predictors include pain level during the active Shingles condition and the size of rash.

Another reason for PHN’s notoriety is that traditional medicine often fails to successfully reduce the severe chronic nerve pain, leaving Shingles survivors significantly physically debilitated and diminishing their quality of life.

PHN is a notoriously difficult chronic pain condition to treat

Traditional medicine generally prescribes the usual regimen of prescription painkillers to lessen pain, along with invasive treatments, usually in the nerve block injection family.

These efforts, much like so many people battling chronic pain from other conditions, fail to offer sustained pain relief, or their success dwindles over time.

Here at Calmare Therapy New Jersey, we are achieving very positive pain reduction outcomes treating patients with postherpetic neuralgia (PHN) using non-invasive and drug-free scrambler therapy.

One of the specific reasons I introduced the Calmare MC-5A device was the wide-ranging chronic nerve pain conditions suitable for non-invasive scrambler therapy.

Since 2011, we have successfully helped people with PHN and even eliminated the chronic nerve pain entirely in some patient cases. 

But using non-invasive Calmare Therapy, I have achieved some outstanding patient outcomes and have been delighted to see these patients’ quality of life escalate after 10 scrambler therapy treatments.

Joan shares a letter about her Calmare research and firsthand PHN treatment experience.

Shingles and chronic pain researchers around the US agree, based upon their clinical trials using the Calmare device to treatment PHN pain:

Dr. Thomas Smith, director of Palliative Care at the Sydney Kimmel Cancer Center, Johns Hopkins University, performed a clinical trial where they achieved an outstanding 95% reduction in pain a month after the treatment with no side effects.

Journal of pain and symptom management

Another study recently published in the Journal of Pain and Symptom Management with 52 random pain participants compared guideline-based drug management with the scrambler. The Calmare participants had a 91 percent reduction in pain compared to a 28 percent reduction in pain for those who used drug management.

ACOS

The American Society of Clinical Oncology (ASCO) completed a clinical trial on the benefits of scrambler therapy:

“Scrambler therapy appears to have a promising effect on post-herpetic neuropathy (PHN) with prompt and continued relief and no side effects.”

The Shingles Vaccine

If you are over age 60, talk to your doctor about getting the shingles vaccine. The benefits are twofold: they reduce your risk of developing shingles; if you do develop shingles, you’ll be more likely to have a mild case, and far less likely to develop PHN.

If you have any questions about PHN and how scrambler therapy may help treat your neuropathic pain, call our pain management team at (201) 933-4440. I will be happy to speak with you personally about your case.